Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV)

CUSIP: 92539P101

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
89,600,000
Total 13F shares
45,570,006
Share change
-1,069,806
Total reported value
$695,801,719
Put/Call ratio
4.9%
Price per share
$15.28
Number of holders
95
Value change
-$28,487,829
Number of buys
54
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 92539P101?
CUSIP 92539P101 identifies VERV - Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) as of Q2 2022

As of 30 Jun 2022, Verve Therapeutics, Inc. - Common Stock, par value $0.001 per share (VERV) was held by 95 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,570,006 shares. The largest 10 holders included Alphabet Inc., FMR LLC, Casdin Capital, LLC, BlackRock Inc., ARCH Venture Management, LLC, VANGUARD GROUP INC, ARK Investment Management LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, and JPMORGAN CHASE & CO. This page lists 95 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.